ArticleMedicine international
Role of lactoferrin in periodontal disease: A meta-analytical assessment of its reliability as a biomarker.
Article in Medicine international. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present systematic review and meta-analysis assessed the clinical utility of lactoferrin as a biomarker for periodontitis by evaluating its association with established periodontal parameters, including probing pocket depth (PPD), clinical attachment loss (CAL) and gingival index (GI). The PICOS question was: 'Are lactoferrin levels different between individuals with periodontitis and periodontally healthy controls, and are these levels associated with disease severity and established clinical periodontal indicators, supporting their role as diagnostic or prognostic biomarkers for periodontitis?'. The present meta-analysis adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and was formally registered in PROSPERO (CRD420251003457). A total of 384 articles were initially identified through various databases, from which 15 studies were selected. A random-effects model was applied to analyse lactoferrin concentration in saliva, serum and gingival crevicular fluid in relation to periodontitis and its periodontal parameters, using standardized mean differences (SMDs) with 95% confidence intervals (CIs). Heterogeneity and potential publication bias were examined through statistical methods, including funnel plots, forest plots, Egger's regression analysis, and Begg's rank correlation test. From the initial pool of 384 studies, 15 satisfied the inclusion criteria for the present meta-analysis, comprising a total of 798 participants (496 patients with periodontitis and 302 healthy controls). The combined SMD was 2.630 (P=<0.010; 95% CI: 1.140-11.180), demonstrating a significant link between elevated lactoferrin levels and periodontitis compared with the controls. Egger's regression test produced a t-statistic of -0.646 (P=0.529), reflecting a lack of significant evidence for publication bias. In addition, there was a significant association between lactoferrin concentration and periodontal indicators such as PPD, CAL and GI. In conclusion, lactoferrin showed potential as a biomarker for periodontal disease, with elevated levels consistently linked to its presence and disease severity. However, significant variability in reported levels across studies and a lack of methodological standardization currently limit its diagnostic reliability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.